A mutational analysis of the internal ribosome entry site in hepatitis C virus in patients treated with pegylated interferon with ribavirin

被引：0
|
作者：
Ogata, K. [1 ,2 ]
Hara, K. [2 ]
Kashiwagi, T. [2 ]
Ide, T. [1 ]
Kumashiro, R. [1 ]
Hamada, N. [2 ]
Watanabe, H. [2 ]
Sata, M. [1 ]
机构：
[1] Kurume Univ, Div Gastroenterol, Dept Med, Kurume, Fukuoka, Japan
[2] Kurume Univ, Sch Med, Div Infect Dis, Dept Infect Med, Kurume, Fukuoka, Japan
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 48卷
关键词：
D O I：
10.1016/S0168-8278(08)60854-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
852
引用
收藏
页码：S320 / S320
页数：1
相关论文
共 50 条
  • [31] Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients
    Bruchfeld, A
    Lindahl, K
    Reichard, O
    Carlsson, T
    Schvarcz, R
    JOURNAL OF VIRAL HEPATITIS, 2006, 13 (05) : 316 - 321
  • [32] Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus
    Foster, GR
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (05) : 685 - 691
  • [33] Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin
    Fouad, Y.
    Khalaf, H.
    Ebraheem, H.
    Rady, H.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 168 - 168
  • [34] Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin
    Soriano, V
    Núñez, M
    Camino, N
    Maida, I
    Barreiro, P
    Romero, M
    Martín-Carbonero, L
    Garcia-Samaniego, J
    González-Lahoz, J
    ANTIVIRAL THERAPY, 2004, 9 (04) : 505 - 509
  • [35] Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin
    Fouad, Yasser M.
    Khalaf, Hanaa
    Ibraheem, Hala
    Rady, Heba
    Helmy, Amal K.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (01) : E67 - E71
  • [36] Chronic ductopenic rejection in patients with recurrent hepatitis C virus treated with pegylated interferon alfa-2a and ribavirin
    Stanca, Carmen M.
    Fiel, M. Isabel
    Kontorinis, Nickolas
    Agarwal, Kaushik
    Emre, Sukru
    Schiano, Thomas D.
    TRANSPLANTATION, 2007, 84 (02) : 180 - 186
  • [37] Mutational and structural analysis of stem-loop IIIc of the hepatitis C virus and GB virus B internal ribosome entry sites
    Rijnbrand, R
    Thiviyanathan, V
    Kaluarachchi, K
    Lemon, SM
    Gorenstein, DG
    JOURNAL OF MOLECULAR BIOLOGY, 2004, 343 (04) : 805 - 817
  • [38] Hepatitis C and treatment with pegylated interferon and ribavirin
    Gotto, J
    Dusheiko, GM
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (10): : 1874 - 1877
  • [39] Cytokine response in chronic hepatitis C (CHC) patients treated with pegylated interferon plus ribavirin
    Trapero-Marugan, M.
    Garcia-Buey, L.
    Munoz, C.
    Moreno-Monteagudo, J. A.
    Borque, M. J.
    Salcedo-Mora, X.
    Moreno-Otero, R.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S227 - S228
  • [40] MENOPAUSE IS ASSOCIATED WITH RELAPSE IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON PLUS RIBAVIRIN
    Stern, Christiane
    Martinot-Peignoux, Michelle
    Ripault, Marie-Pierre
    Boyer, Nathalie
    Cardoso, Ana Carolina
    El Ray, Ahmed
    Asselah, Tarik
    Valla, Dominique
    Marcellin, Patrick
    HEPATOLOGY, 2010, 52 (04) : 788A - 788A
12345